remdesivir Archives - chatsaudicam.com

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

04/14/2021 antibodies, coronavirus, Coronavirus Disease COVID-19, Genome, genomic, hospital, protein, remdesivir, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), spreads globally, new

Health News

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

04/12/2021 Antiviral Drug, cell, coronavirus, Coronavirus Disease COVID-19, drugs, enzyme, Genome, Guanine, Immune Response, molecule, protein, remdesivir, Respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Structural Protein, syndrome, virus

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and

Health News

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

04/12/2021 Antiviral Drug, cell, Compound, coronavirus, Coronavirus Disease COVID-19, enzyme, Genome, Health Systems, Immune Response, in vitro, molecule, remdesivir, research, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, virus

In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute

Health News

Researchers identify several novel SARS-CoV-2 inhibitors

04/09/2021 Antibody, Assay, coronavirus, Coronavirus Disease COVID-19, Drug Repurposing, Monoclonal Antibody, protein, remdesivir, research, Respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, virus

Researchers in London, UK, have identified several compounds with SARS-CoV-2 inhibiting properties, that potentially may be developed into antiviral solutions

Health News

FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects

04/03/2021 Cancer, cell, Disease Modeling, drugs, fruit, Genes, HIV, lungs, medicine, muscle, pandemic:, protein, remdesivir, research, SARS, SARS-CoV-2, virus

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-CoV-2-;the virus that causes

Health News

Researchers identify new drug candidates for treating patients with severe COVID-19

03/28/2021 Cancer, cell, Disease Modeling, drugs, fruit, Genes, HIV, lungs, medicine, muscle, pandemic:, protein, remdesivir, research, SARS, SARS-CoV-2, virus

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2–the virus that causes

Health News

A precursor to remdesivir shows therapeutic potential for COVID-19

02/09/2021 Antiviral Drug, Clinical Trial, coronavirus, Coronavirus Disease COVID-19, Drug Repurposing, drugs, efficacy, liver, metabolism, Metabolite, Nucleoside, pandemic:, Pharmacokinetics, Placebo, Polymerase, remdesivir, Respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, Transcription, virus

In the pursuit of effective antiviral drugs to counter the current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute

Health News

Covid-19: Features that could make someone coronavirus super-spreader identified

11/20/2020 ageusia, Anosmia, boris johnson, Britain, China, coronavirus, COVID, COVID-19, Genes, hydroxychloroquinine, interferons, London, pandemic:, plasma, pneumonia, pregnancy, quarantine, remdesivir, SARS-CoV-2, social distancing, Stillbirth, UNICEF, United Nations, World Health Organization, Wuhan

Using computer-generated models, scientists have simulated sneezes in different types of people, and identified the biological features that could make